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Abstract
Background: Rybp (Ring1 and YY1 binding protein) is a zinc finger protein which interacts with
the members of the mammalian polycomb complexes. Previously we have shown that Rybp is
critical for early embryogenesis and that haploinsufficiency of Rybp in a subset of embryos causes
failure of neural tube closure. Here we investigated the requirement for Rybp  in ocular
development using four in vivo mouse models which resulted in either the ablation or
overexpression of Rybp.
Results: Our results demonstrate that loss of a single Rybp allele in conventional knockout mice
often resulted in retinal coloboma, an incomplete closure of the optic fissure, characterized by
perturbed localization of Pax6 but not of Pax2. In addition, about one half of Rybp-/- <-> Rybp+/+
chimeric embryos also developed retinal colobomas and malformed lenses. Tissue-specific
transgenic overexpression of Rybp in the lens resulted in abnormal fiber cell differentiation and
severe lens opacification with increased levels of AP-2α and Sox2, and reduced levels of βA4-crystallin
gene expression. Ubiquitous transgenic overexpression of Rybp in the entire eye caused abnormal
retinal folds, corneal neovascularization, and lens opacification. Additional changes included defects
in anterior eye development.
Conclusion: These studies establish Rybp as a novel gene that has been associated with coloboma.
Other genes linked to coloboma encode various classes of transcription factors such as BCOR, CBP,
Chx10, Pax2, Pax6, Six3, Ski, Vax1 and Vax2. We propose that the multiple functions for Rybp in
regulating mouse retinal and lens development are mediated by genetic, epigenetic and physical
interactions between these genes and proteins.
Background
The vertebrate eye is a complex neurosensory organ. Nor-
mal function of the eye requires precise spatial organiza-
tion and interaction between individual tissues to respect
the laws of optics. During embryonic development, recip-
rocal inducing events result in the formation of the lens
and the retina that originate from progenitor cells located
in the head surface ectoderm and neuroepithelium of the
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ventral diencephalon, respectively (see reviews:[1,2]).
Abnormal lens and retinal development can cause iso-
lated or widespread ocular abnormalities that can obstruct
vision at different levels and lead to blindness (reviewed
in [3]).
Between embryonic day E9.5 and E11.5 of mouse devel-
opment, the optic vesicle undergoes dorso-ventral pat-
terning of the neuroepithelium followed by its
invagination to form the bilayered optic cup [4]. This
process gives rise to the optic fissure, allowing blood ves-
sels originating from the vascular mesoderm to enter the
developing eye. By E13.5, the nasal and temporal retina
on either side of the choroid fissures fuses around the
optic nerve axons and blood vessels. Failure of this closure
results in a specific developmental abnormality, called
ocular coloboma. Ocular coloboma is often seen in asso-
ciation with severe neurological and/or craniofacial
abnormalities [5] or can develop as an isolated condition
[6].
Lens differentiation at E12.5 is marked by cellular elonga-
tion of the lens cells forming the posterior part of the lens
vesicle [7]. Differentiating lens fiber cells upregulate
expression of various classes of structural proteins includ-
ing crystallins, intermediate filament bead proteins, and
cytoskeletal, membrane, and channel proteins. Abnormal
lens fiber cell differentiation disrupts lens homeostasis
leading to precipitation of lens proteins resulting in lens
opacification and perturbed vision (see review [8]).
At the molecular level, a significant number of genes
involved in the control of eye development also regulate
brain development [9]. The most notable classes are
homeobox genes such as Lhx2, Otx2, Pax6, Rx and Six3,
and the basic helix-loop-helix genes Math5, Neurod1 and
Neurog2. In contrast, other genes play specialized roles
during lens (e.g., Foxe3, Mab21like1, c-Maf, Pitx3, Sox1 and
Hsf4) or retinal (e.g., Chx10,  Mab21like2,  Six6/Optx2,
Vax1, Vax2) development [10,11]. Several global regula-
tory genes are also integral to normal ocular development.
For example, Brg1 [12], Snf2h [13] and Sox2 [14] regulate
embryonic development prior to the organ formation.
Later, Brg1 and Snf2h are thought to regulate retinal [15]
and lens development [16], and Sox2 is required for lens
placode formation [17] and optic cup formation [18]. AP-
2α [19,20], pRb [21] and its partners, the E2Fs [22] play
roles in both retinal and lens differentiation.
Rybp (RING1 and YY1 binding protein) is an evolutionar-
ily conserved protein with a zinc-finger motive that was
identified first as an interacting partner for the Polycomb
group protein Ring1A [23]. Polycomb group (PcG) pro-
teins function as transcriptional repressors acting part
through histone modification, and are believed to be
important regulators of organogenesis and cell lineage
specification [24,25]. Recent studies in Drosophila  have
shown that Drosophila RYBP depends upon PcG proteins
to repress transcription, suggesting that Rybp could be
classified as a PcG protein itself [26]. Other studies have
demonstrated Rybp's interaction with DNA binding tran-
scription factors [27-29] as well as with apoptotic [30] and
ubiquitinated proteins [31]. Although the precise molecu-
lar function of Rybp is not yet known, these interactions
suggest that Rybp may be a multifunctional developmen-
tal regulator. Indeed, we have shown recently that the
Rybp is required both for early mouse development and
for proper brain formation. Specifically a dose-dependent
role in the central nervous system (CNS) for Rybp was
uncovered: haploinsufficiency in the subset of embryos
caused an exencephalic phenotype due to imperfect clo-
sure of the neural tube [32].
Given established parallels between brain and eye devel-
opment, we hypothesized that Rybp may also play a role
in ocular development. Here we determined Rybp protein
localization patterns in the murine eye and analyzed the
function of Rybp  in four mouse models representing
reduced or increased Rybp gene dosage. These studies have
shown that aberration in the normal protein levels of
Rybp can result in retinal coloboma, abnormal lens and
anterior eye development, and corneal neovasculariza-
tion.
Results
Rybp is expressed in multiple tissues of the mouse 
embryonic eye
In previous work, we reported the localization of Rybp in
the developing CNS [32]. The common embryonic origin
of the brain, lens, and retina from the primitive ectoderm
prompted us to determine the protein localization of
Rybp during mouse ocular development (Fig. 1). At
E10.5, Rybp staining first strongly marked the head sur-
face ectoderm surrounding the invaginating lens placode
(Fig. 1A). Weak, speckled expression was also seen
beneath the surface ectoderm, in the periocular mesen-
chyme, and throughout the emerging optic cup (Fig. 1A).
From E11.5, Rybp appeared both in the anterior cells of
the lens vesicle and in the nuclei of the elongating primary
lens fiber cells (Fig. 1B). Similar to the lens, speckled
expression was also evident in the optic cup, with a higher
density of positive cells towards the ventral and marginal
portion (Fig. 1B). Expression of Rybp in the hyaloid
plexus was also detected (Fig. 1B). With progressive devel-
opment, expression of Rybp persisted in the cells of the
hyaloid cavity (Fig. 1C, D) and the head surface ectoderm.
Between E14.5 and E16.5, Rybp localized in the differen-
tiating secondary fiber cells of lens (E16.5; Fig. 1C and 1E)
and in the ventral part of the neuroretina (E16.5; Fig. 1C,
F). At E16.5 Rybp was also detected in the lens epitheliumBMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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(Fig. 1C, G). In the cornea, Rybp was expressed in the cor-
neal epithelium and some cells of the corneal stroma (Fig.
1G). Rybp displayed non-uniform weak staining in the
cells of the optic nerve and stronger staining in the peri-
optic mesenchyme (Fig. 1H). One marked change in the
expression pattern of Rybp during mouse eye develop-
ment is that its widespread expression in undifferentiated
cells of the retina becomes restricted to a layer-specific
Rybp localization during prenatal mouse ocular development Figure 1
Rybp localization during prenatal mouse ocular development. (A-H) Sagittal sections were immunostained for Rybp 
(brown) and counterstained lightly with hematoxylin (purple) at E10.5 (A), E11.5 (B) and E16.5 (C-H). Higher-magnification of 
areas stained with the Rybp antibody indicated in (C) are shown in panels D-G. (I-L) Panels show the gradual increase of Rybp 
expression in the developing neural retina at E10.5 (I), E11.5 (J), E13.5 (K) and E18.5 (L). C; cornea, E; embryonic, GCL; gan-
glion cell layer, INL; inner nuclear layer, L; lens, NR; neuroretina, ON; optic nerve, PM; periocular mesenchyme, SE; surface 
ectoderm, OC; optic cup. Magnifications: A (×460); B(×320); C(×250); D(×800); E-H(×400); I(×630); J(×460), K(×320); 
L(×250).BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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expression profile marking the gradually emerging gan-
glion (GCL) and inner nuclear (INL) cell layers (Fig. 1I–
L). Rybp's expression is robust in the ganglion cell layer of
the differentiating retina, but strong staining is also visible
in the INL and in a few cells of the future photoreceptor
layer of the neuroretina (Fig. 1L).
Next, we analyzed the localization of Rybp in two day (P2,
Figs. 2A,C,E,G), and twenty one day old (P21, Figs. 2B,D)
mouse eyes. In the postnatal P2 retina, Rybp showed
intense staining in the GCL and in the differentiating INL
of the retina (Fig. 2A). At P21, Rybp still was expressed in
the GCL and in the INL, specifically in its dorsal part likely
coincident with the bipolar and horizontal cell layers (Fig.
2B). Although Rybp was detected in the early stages of pri-
mary lens fiber cell development (Fig. 1B), in the more
mature lens its expression was attenuated both in fully
elongated primary lens fiber cells and in the lens epithe-
lium (Figs. 2C and 2D). However, strong expression of
Rybp in the lens was seen in the transitional zone where
the secondary lens fiber cells are formed (Figs. 2C and
2D). At P2.0, Rybp was expressed in the majority of lens
epithelial cells, and sporadic expression also was observed
in the corneal epithelium, stroma, and basal membrane
(Fig. 2E). By P21.0, Rybp is no longer expressed in the lens
epithelium but still is weakly expressed in the corneal epi-
thelium (Fig. 2F). Finally, Rybp was strongly expressed
postnatally in the connectiva (Fig. 2G), and uniform
localization of Rybp was observed around the newborn
optic nerve (Fig. 2H). This dynamic and cell-type
restricted expression pattern of Rybp (Figs. 1 and 2) raises
the possibility that Rybp may have specific functional
roles in the generation/maintenance of particular cell
types during mammalian eye development.
A subset of the Rybp+/- embryos exhibits retinal coloboma
Previously we reported that a subset of Rybp heterozygous
null embryos exhibited perturbed brain development
including forebrain overgrowth and exencephaly [32]. As
the retina forms from the forebrain, we next examined the
possibility of aberrant eye development in these animals.
We found that 32% (6/19) of Rybp+/- exencephalic mice
examined at several stages of development (from E12.5 to
postnatal stages) showed retinal/optic nerve coloboma
(compare Fig. 3A and 3B). Colobomas of this type often
are caused by an incomplete closure of the optic fissure
Rybp localization in the postnatal mouse eye Figure 2
Rybp localization in the postnatal mouse eye. Sagittal sections of the eye at the level of the optic nerve at P2.0 (A, C, E, 
G, and H), and P21 (B, D, and F) were immunostained for Rybp. Shown are the retina (A, B), lens (C, D) cornea (E, F), connec-
tiva (G) and optic nerve (H). C; cornea, Ep; corneal epithelium, GCL; ganglion cell layer, INL; inner nuclear layer, L; lens, LE; 
lens epithelium, ON; optic nerve, PLF primary lens fiber cells, T; transitional zone P; postnatal day. Magnification: (320×)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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that occurs normally at E13.5 [33]. Rybp+/- colobomas
were observed both bilaterally and unilaterally. In addi-
tion, Rybp+/- eyes had thickened neuroretinas, their
lenses were ventrally rotated and misplaced within the
eyeball (see Fig. 3B in comparison to Fig. 3A). The optic
nerve was also frequently regressed (Fig. 3F). One possible
explanation for the development of colobomas is that the
decreased level of Rybp in the mutant retinas influences
the normal distribution of regulatory proteins such as
Pax6 [34-36] or Pax2 [33,37,38]. Both Pax6 and Pax2
have been shown to be essential for proper closure of the
optic fissure. Accordingly, we tested whether immuno-
localization of Pax6 and Pax2 was affected in the mutant
Rybp eyes. Normally, Pax6 protein is localized in the ven-
tral side of the retina but disappears from the developing
optic nerve after E12.0 in wild-type animals [39]. In the
Rybp mutant embryos, Pax6 expression spreads across the
entire thickness of the retina, expanding to its margin
(Figs. 3C, D). In contrast, the localization of Pax2 in
mutant eyes were unchanged (Fig. 3E compare to 3F).
The proper ratio between neural progenitor and postmi-
totic neuronal cell types is important for normal retinal
development and disturbed morphogenesis of this proc-
ess can lead to colobomas. [40]. Accordingly, we investi-
gated whether the ratio between early- and late-born
neurons changed in the mutant retinas exhibiting the
coloboma phenotype. In the prenatal mutant retina,
expression of specific neuronal cell fate markers was sim-
ilar to the expression of these markers in the retina of con-
trol mice. These included Tuj1 (marks early neural cell
types; Fig. 4A,B), NeuN (postmitotic, marks late neuronal
cell types; Fig. 4C, D) and nestin (marks neural progenitor
cells; Fig. 4E, F). The apparent normal distribution of
these neuronal markers shows that the neuronal cell dif-
ferentiation is not affected in the Rybp mutant retinas and
probably is not the direct cause of the failure of optic fis-
sure closure.
Rybp-/- <-> Rybp+/+ chimeric embryos show a series of eye 
defects
Early lethality of Rybp -/- embryos [32] prevented our anal-
ysis of the effect of a complete loss of Rybp during eye
development. However, chimeric mice (n = 90) have been
generated from Rybp homozygous null -/- and wild type
(+/+) ES cells, and 20% of them showed low overall con-
tribution of Rybp -/- ES cells and displayed forebrain
abnormalities [32]. Half of the chimeric embryos (exam-
ined between E9.5 and E14.5) with brain abnormalities
also showed eye defects similar to those described above
for the Rybp+/- embryos. These included retinal colobo-
mas (Figs. 5A and 5B), and defects in lens formation
(compare Figs. 5D to 5C and 5F to 5E). In addition, in an
E13.5 chimera, the separation between the lens epithe-
lium and the surface ectoderm was compromised (com-
Retinal coloboma in Rybp+/- mouse embryo Figure 3
Retinal coloboma in Rybp+/- mouse embryo. (A-B) 
Hematoxylin and eosin- stained coronal sections of normal 
(A) and Rybp heterozygous null (B) eyes at E14.5. The neu-
roretina of the mutant eye is thickened and fails to close 
leading to the formation of coloboma (B; arrowhead). (C-D) 
Immunolocalization of Pax6 in wild type (C) and mutant (D) 
eyes. Pax6 is normally expressed in the ventral side of neu-
roretina. In the mutant eyes it shows broader expression in 
the retina and it is also more posteriorly positioned in the 
transition zone of the lens (C compare to D). (E-F) Immu-
nolocalization of Pax2 in wild type (E) and mutant (F) eyes. L; 
lens, NR; neuroretina, ON; optic nerve, V; ventral, T; transi-
tional zone. HE; hematoxylin and eosin. Magnifications: A-
D(×320); E-F(×460)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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pare Fig. 5H to 5G). Our findings again indicate that
normal lens and retinal development cannot occur in the
context of suboptimal Rybp dosage.
Overexpression of Rybp results in lens, retinal and corneal 
defects
Next we employed a conditional ectopic overexpression
strategy [41] to assess the effects of Rybp overexpression in
the lens. First we introduced an inducible Rybp – green
fluorescent protein (EGFP) fusion gene into the mouse
genome (ROSA26-RYBP/EGFP  mice; Fig. 6A). Proteins
were extracted from the targeted ES cell lines (ROSA26-
RYBP/EGFP cell line) prior to and following Cre induction
(ROSA26-RYBP/EGFP; Cre cell line), and the expected 66
kDa Rybp/EGFP fusion protein was observed (Fig. 6B). To
demonstrate that this fusion protein is functional and can
Multiple ocular abnormalities in Rybp-/- <-> Rybp+/+ chimeric  embryos Figure 5
Multiple ocular abnormalities in Rybp-/- <-> Rybp+/+ 
chimeric embryos. (A-B) Whole mount eyes from E13.5 
wild type (A) and chimeric (B) embryos. The normal eye is 
symmetrical, while in the chimeric eye the chorioid fissure 
fails to close, leaving a large coloboma (arrowhead). (C-F) 
Histology of coronal sections of E13.5 wild type (C, E) and 
chimeric (D, F) eyes. Higher-magnification views of areas 
indicated in (C) and (D) are shown in (E) and (F), respec-
tively. In the chimeric embryos, the eyes are rotated, lens 
development is delayed and overall lens size is reduced, and 
the retina is asymmetric with thickening on one side (F; 
arrowhead). (G-H) At E13.5 in the normal eye there is a 
mesenchymal cell layer between the SE and the LE (G; black 
arrowhead). In the chimeric eye, the lens epithelium is con-
tinuous and mixed with the mesenchyme and the surface epi-
thelium (H; black arrowhead). H; hyaloid cavity, L; lens, LE; 
lens epithelium, NR; neuroretina, SE; surface ectoderm. Mag-
nification: A-B (×120); C-D (×60); E-F (160×); G-H (×400)
Progenitor cell fate is not changed in the mutant retinas of  the Rybp heterozygous eyes Figure 4
Progenitor cell fate is not changed in the mutant ret-
inas of the Rybp heterozygous eyes. Wild type (A, C, E) 
and Rybp heterozygous null eyes exhibiting retinal coloboma 
(B, D, F) were stained with TUJ1 (A, B), NeuN (C, D) and 
Nestin (E, F) at E14.5. (A-B) TUJ1 staining, marking early neu-
ronal cell types including ganglion cells of the retina, is com-
parable in the wildtype and mutant mice. (C-D) Similarly, 
NeuN, a postmitotic neural marker, shows no significant 
alteration in the mutant retinas. (E-F) The distribution of nes-
tin, an intermediate filament marker for neural progenitor 
cells, is not affected in the mutant retinas. L; lens, NR; neu-
roretina, Magnifications: (×460)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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bind to Ring1A as described earlier [23], the excised cells
(ROSA26-RYBP/EGFP; Cre cell line) were transiently
transfected with Flag-tagged Ring1A, and lysates were
immunoprecipitated with either RYBP or GFP antibodies
and blotted with a Flag antibody. As expected, the RYBP/
EGFP fusion protein was found together with Ring1A in
vivo (Fig. 6C).
The ROSA26-RYBP/EGFP mice were crossed with two dif-
ferent reporter mouse lines and the proper expression of
Lens-specific and ubiquitous expression of RYBP/EGFP fusion protein Figure 6
Lens-specific and ubiquitous expression of RYBP/EGFP fusion protein. (A) Scheme illustrating the strategy used to 
generate a Cre recombinase-mediated conditional ectopic Rybp allele by targeting the ROSA26 locus (for details, see Methods). 
The position of the hybridization probe (dot) and restriction enzyme EcoRV (arrows) used for detecting the correct homolo-
gous integrants by Southern blotting is shown. The 5' probe used detects an 11 kb wt band and a 3.8 kb targeted band, due to 
the presence of an extra EcoRV site in the targeted allele. The exons shown as open boxes. Cre: Cre-recombinase, EGFP; 
enhance green fluorescent protein, Neo; neomycin phosphotransferase. (B) Western blotting analysis showing the expression 
of the RYBP/EGFP fusion in lysates of cells that have been exposed to Cre recombinase. Lane 1, lysates from ROSA26 knock-in 
ES cells prior to Cre exposure (-Cre); lane 2, lysates from Rosa26 knock-in ES cells after Cre exposure (+Cre); lane 3, lysates 
from ES cells transfected with an RybpFlag construct, as a positive control. The blot was probed with the anti-Rybp antibody. 
(C) Ectopically expressed Rybp can associate with Ring1A. Lanes 1–2: Cells lysates of transfected ES cells blotted with anti-Flag 
antibody showing that both Ring1aFlag (Lane 1) and Maf1Flag (Lane 2) strongly expressed in the transfected cells; Lane 1, Cells 
transfected with Ring1AFlag construct., Lane 2, Cells transfected with Maf1Flag construct. Lane 3–4: Cells transfected with either 
Ring1AFlag (Lane 3) or with MAF1Flag (Lane 4), then immunoprecipitated with Rybp and blotted with anti-Flag antibody. Lane 3 
shows the 57 kdDa Ring1AFlag fusion protein as the result of the association with the RYBP/EGFP fusion protein. Maf1 cannot 
bind Rybp (Lane 4). (D) P1 eyes harvested from double transgenic (ROSA26-RYBP/EGFP; αA-crystallin/Cre mice) and wildtype 
(WT) animals shown in dark field and fluorescence. (E) Lens specific over-expression of the RYBP/EGFP fusion protein in new-
born (P2) lenses. EGFP immunohistochemistry shows the overexpression of the transgene in the ROSA26-RYBP/EGFP; αA-crys-
tallin/Cre lens (TG). The wild-type lens shows only background staining (WT). (F) Bright-field and dark-field pictures of E11.5 
littermates. All embryos that genotyped double transgenic for ROSA26-RYBP/EGFP;β-Actin/Cre also exhibited detectable EGFP 
fluorescence (TG) when compared to wildtype (WT) littermates. Magnification: D (×40); E (×10)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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the fusion protein was confirmed by fluorescent micros-
copy: lens specific expression was seen for the ROSA26-
RYBP/EGFP;αA-crystallin/Cre double transgenics (Fig. 6D)
and ubiquitous expression for the ROSA26-RYBP/EGFP;β-
Actin/Cre double transgenics (Fig 6F). Aberrant lens mor-
phology of the ROSA26-RYBP/EGFP;  αA-crystallin/Cre
mice is shown in Fig. 7. Although the P2 embryonic lenses
showed only subtle abnormalities in fiber cell morphol-
ogy (7A–B), older mice developed severe opacities of the
lens resulting in a collapse of lens fiber mass (Figs. 7C–D).
Eyes from ROSA26-RYBP/EGFP;  β-Actin/Cre  mice were
examined at embryonic (E16.5, E18.5), postnatal (P1–P4,
P7, P14, P21) and adult stages (2, 3, 6 month) (Fig. 8, and
data not shown). This ubiquitous overexpression of
RYBP/EGFP led to the abnormal formation of a number
of ocular tissues. The most frequent phenotype seen (in
35% of the mice) was neovascularization of the corneas
(compare Fig. 8C–D to 8A–B). These structural changes
were visible at postnatal stages (P7-21) during which the
stromal layer thickened. When hemizygous mice were
mated to obtain mice homozygous for the RYBP/EGFP
transgene, the penetrance of the phenotype increased to
80%. Small vessels were apparent in the stroma of the cor-
nea under bright field microscopy, and by 2–4 months
postnatal, gross corneal neovascularization was visible
(data not shown). Electron microscopy studies showed
that the capillaries are already present at birth in the trans-
genic corneas (Fig. 8E, F). This was further supported by
immunohistochemistry using an anti-CD34 antibody
which marked the newly formed vessels of the mutant
corneas (data not shown). Aside from neovascularization,
other observed ocular phenotypes included irregular fold-
ing of the retina, retinal coloboma, defects in anterior eye
development (absence of the vitreous body, absence of
the anterior chamber), and lens opacification during later
adulthood (Fig. 8G,H and data not shown). In summary
we have developed transgenic mouse models in which
expression of Rybp in the lens disrupted normal fiber cell
differentiation and ubiquitous expression of Rybp resulted
in corneal neovascularization and defects in the anterior
eye development. These models suggest that normal eye
development is sensitive for the proper dose of Rybp and
that improper dosage of Rybp causes multiple eye abnor-
malities.
Genes with altered expression level in the Rybp transgenic 
lenses
As a first attempt to elucidate the molecular basis of
abnormal lens fiber cell differentiation of the ROSA26-
RYBP/EGFP;  αA-crystallin/Cre  mice (Figs 7, 8), we per-
formed expression analysis of the genes involved in this
process including major lens structural proteins, selected
cell adhesion molecules, and major transcription factors
implicated in lens development (Fig. 9). Total RNA from
P1 transgenic and control lenses was used to synthesize
cDNA, and quantitative RT-PCR was performed. The
expression level of both Rybp  and  EGFP  mRNA was
increased 16-times compared to the non-transgenic con-
trol as expected. From the major lens structural proteins,
the Cryba4 transcript showed a seven-fold reduction in
transgenic lenses, while the expression of other crystallins
and filensin was unchanged. From the tested cell adhesion
molecules, α6-integrin mRNA level was five-times reduced
while other integrins (α5- and β1-integrins) remained
unchanged. Among tested transcription factors, AP-2α
mRNA level was 30-times and Sox2 was 12-times ele-
vated. The level of transcription factors Pax6, Prox1, MafA,
MafB  and  c-Maf  did not change significantly in the
ROSA26-RYBP/EGFP;  αA-crystallin/Cre  lenses. These
results further confirm that normal lens development
depend on the Rybp gene dosage. RNA microarray studies
may need to be conducted in the future to provide further
insight into which membrane proteins, gap junctions and
β/γ-crystallins are being affected.
Discussion
Rybp encodes an essential regulatory protein involved in
early post-implantation development of the mouse
embryo. In addition, Rybp plays important roles in orga-
Abnormal lens development in the lens-specific Rybp trans- genic mice Figure 7
Abnormal lens development in the lens-specific Rybp 
transgenic mice. (A-D) Histological appearance of wild 
type (A, C) and ROSA26-RYBP/EGFP; αA-crystallin/Cre trans-
genic (B, D) lenses at early postnatal (P2) development (A, B) 
and adulthood (3 month) (C, D). (A, C) Wild type eyes with 
normal morphology of the lens epithelium and fiber cells. (B, 
D) Transgenic eyes showing cortical inhomogeneity as a sign 
of developing cataract and impaired lens development (B). 
Lenses of adult transgenic mice (3 month) show progressed 
cataractous morphology (D). CA; cataract, L; lens, LE; lens 
epithelium, T; transitional zone, TG; transgenic, WT; wild 
type; P; postnatal. Magnification: A-B (×160); C-D (×250); E-F 
(×120)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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nogenesis as evidenced by disrupted development of the
forebrain found both in Rybp heterozygous null and chi-
meric embryos [32]. Here we characterized the protein
localization and in vivo function of Rybp in another organ
– the developing mouse eye. We show that Rybp  is
required for normal retinal and lens development, and
may also be involved in the formation of the anterior eye
segment.
Our previous work revealed that during CNS develop-
ment, Rybp is predominantly localized in postmitotic
neurons and differentiated cell types of the developing
mouse embryo [32]. In the present study, we show that in
the developing mouse eye, Rybp also becomes robustly
made in the differentiating layers of the neuroretina
including the ganglion and inner nuclear layer cells. This
suggests once again a possible role for Rybp in cell cycle
exit or the commitment to differentiation. Gaining further
insight into the precise cellular role of Rybp during mouse
ocular development likely requires a conditional mutant
version of the gene where Rybp can be eliminated in spe-
cific cell lineages or at specific time points of embryonic
development.
The major phenotypic malformation observed in all Rybp
mouse models (heterozygous, chimeric and transgenic,
see Table 1) was the failure of the closure of the optic fis-
sure, retinal coloboma. Morphological analysis of embry-
onic eyes showed that 32% of Rybp  deficient
(heterozygous) and 50% of chimeric mice have eye colo-
boma in conjunction with brain defects, but coloboma
was also seen in the Rybp transgenic mice that did not dis-
play obvious brain defects. A number of mammalian
genes encoding transcription factors (BCOR, CBP, Chx10,
Cited2, c-Maf, Foxg1, Pax2, Pax6, Ptch, Six3, Ski, Vax1 and
Vax2), signaling molecules (Jnk1, Jnk2 and Shh), or mem-
bers of the retinoic acid pathway have been associated
with coloboma [5]. Our study describes Rybp as a novel
gene associated with coloboma. While the molecular and
cellular mechanisms underlying this condition are still
poorly understood, they likely involve perturbations in
cell adhesion, cell shape, cell proliferation, cell death,
and/or the extracellular matrix.
Aside from the retinal colobomas, a wide range of lens
abnormalities were found in the Rybp mouse models. In
both Rybp heterozygous and chimeric eyes, ventral rota-
Corneal neovascularization and irregular retinal development in ubiquitous Rybp transgenic mice Figure 8
Corneal neovascularization and irregular retinal development in ubiquitous Rybp transgenic mice. (A-F) Neo-
vascularization of the ROSA26-RYBP/EGFP;β-Actin/Cre transgenic corneas in adult (2-month old) mice. Sagittal sections from wild 
type (A, B) and transgenic eyes (C, D) were stained with hematoxylin and eosin; boxes in panels A and C show areas magnified 
in panels B and D, respectively. The appearance of vessels (arrowheads in panel D) in the stroma of transgenic mice only is 
indicative of corneal neovascularization. The epithelium of the transgenic mice is also disorganized (D; open arrowhead). (E-F) 
Electron micrographs showing the corneal stroma next to the corneal epithelium in transgenic (Tg) and wild-type (Wt) animals 
at three weeks of age. While the stroma of the wild-type animal is not vascularized, a capillary (Ca) is seen close to the corneal 
epithelium in the transgenic animal. (G-H) Abnormal retinal folding and colobomas in newborn β-Actin/RYBP Tg mice (H) in 
comparison to normal retina in controls (G). C; cornea, Col; coloboma, E; epithelium, Ep; corneal epithelium; L; lens, NR; neu-
roretina, WT; wild type, S; stroma, TG; Transgenic. Magnification: A, C (×200); B, D (×460); G-H (×160)BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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tion of the lens was found in association with coloboma
(see Fig. 3 and 5). A similar phenotype has been reported
for  Otx  mutant mice [42]. Lenses of Rybp  chimeric
embryos showed abnormal separation of the lens vesicle
from the surface ectoderm (Fig. 5), a condition found in
Pax6 heterozygous [43] and Foxe3 homozygous [44]
mouse embryos. Transgenic lenses overexpressing Rybp
developed abnormally differentiated lenses at birth (if not
earlier), and this condition further deteriorated with age
resulting in a total collapse of the lens fiber mass (see Fig.
7). This demonstrates that high level of Rybp disrupts nor-
mal fiber cell differentiation and maturation. Similar phe-
notype was observed when AP-2α  transcription factor,
individual E2Fs or growth factors were overexpressed in
lens specific manner ([19,45], see review [46]). Whether
excess of Rybp interferes with adhesion and migration
(like AP-2α), cell cycle (like E2Fs), terminal differentia-
tion (like TGFβ) of secondary fiber cells or acts via com-
pletely different mechanisms, requires further studies.
Indeed, RYBP was shown to be involved in specification
of function within the family of E2F transcription factors
in cell culture systems [28] however this has not been
investigated in vivo during lens fiber cell differentiation.
Ubiquitous overexpression of Rybp  caused similar lens
defects and additionally led to corneal neovascularization
(see Fig. 8). Genes such as VEGF, FGF2 and MMP-2 have
already been associated with corneal neovascularization
[47-50]. A possible connection between Rybp and angio-
genesis warrants further investigation, especially in light
of the observation that during embryonic development
Rybp is expressed in hyaloid vessels and in the endothe-
lium of blood vessels outside of the eye (Fig. 1; Pirity and
Schreiber-Agus, unpublished data).
The variable penetrance of the phenotypes may indicate
that expression and/or function of the retained wild type
Rybp allele is being modified differentially in affected or
non-affected animals. This is also supported by our previ-
ous observation that the penetrance of the exencephaly, a
previously described heterozygous semipenetrant pheno-
type, was influenced by genetic background [32]. Indeed
the phenomenon "semi-penetrance" is a common obser-
vation in genetically-engineered mice.
One potential molecular mechanism for abnormal eye
development in Rybp mice could relate to Rybp's role in
Polycomb group protein transcriptional regulation [23].
Polycomb proteins function in multiprotein complexes to
regulate expression of homeotic and other regulatory
genes during embryonic development [51-57] and also in
eye development [58,59]. Notably, in our limited gene
expression studies using a candidate approach (Figure 9),
several key eye regulators were found to be significantly
affected in the Rybp transgenic lenses examined, including
Sox2 and AP-2α (see also [60,18,19,61]) as well as were
some of the crystallins [62]. Moreover, Pax6 localization
in retina and lens appears affected in the Rybp  hetero-
zygous null mice (Figure 3). Taken together, our findings
Table 1: Summary of ocular phenotypes
Ocular phenotype Examined Mutant No. with ocular phenotype/
No. of examined mutants
Penetrance (%)
Coloboma (by E18.5) Rybp heterozygous (+/-) mice 5/15 33
Coloboma, lens defects (By E14.5) Chimeric mice Rybp-/- <-> 6 exencephalic/19 32
Rybp+/+ 3 non exencephalic/19 16
Cataract (by 3 month) ROSA26-Rybp/EGFP; αA-crystallin/Cre Tg/+ mice 44/75 59
Neovascularization (by 3 month) ROSA26-Rybp/EGFP; β-Actin/Cre Tg/+ mice 30/87 35
Neovascularization (by 3 month) ROSA26-Rybp/EGFP; β-Actin/Cre Tg/Tg mice 30/38 80
Coloboma, irregular retinal folds, 
anterior chamber defects (by P7)
ROSA26-Rybp/EGFP; β-Actin/Cre Tg/Tg mice 11/38 29
Quantitative RT-PCR analysis of transgenic lenses overex- pressing Rybp Figure 9
Quantitative RT-PCR analysis of transgenic lenses 
overexpressing Rybp. Relative change in expression level 
of Rybp, Sox2, AP-2α, βA4-crystallin and α6-Integrin transcripts 
in the P1 lens. All data are normalized to B2M expression 
level. Error bars indicate standard deviation.BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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suggest that Rybp  may be regulating the expression of
other developmental regulators, whose altered levels in
the Rybp mouse models could be causal to the observed
phenotypes. Further studies are necessary to determine
whether Rybp directly regulates these (and other) genes,
and whether this regulation occurs via the interaction of
Rybp  with Polycomb group transcriptional repressors.
Interestingly, the abnormal anterior eye formation of
Ring1-deficient mice, which is exacerbated in compound
YY1+/-Ring1-/- mice, is similar to what we have observed
in the Rybp mutant mice ([59] and Fig. 7H). Since both
YY1 and Ring1A interact with Rybp and with other class II
PcG proteins, it is possible that these proteins functionally
interact to orchestrate normal vertebral eye development.
Conclusion
Collectively, the present work provides the first in vivo evi-
dence for a role of the Polycomb group binding protein
Rybp in mouse eye development and disease. Further
studies need to address the molecular basis of this role
and to determine how Rybp functionally relates to other
known regulators of ocular processes.
Methods
Es cell injections, mouse breeding, husbandry and 
genotyping
ES cell injections, mouse breeding, husbandry, and geno-
typing of the Rybp knockout colonies was as previously
described [32]. Chimeric embryos were generated by
microinjecting Rybp-/- R1 ES cells (129/Sv × 129-Cp; [63])
into blastocysts derived from wild-type (Rybp+/+) mice
(C56/BL6), as described previously [32]. The αA-crystallin/
Cre transgenic mice were a kind gift of M.L. Robinson
(Columbus, Ohio, USA); [64]. Analysis of the Cre-medi-
ated recombination pattern in the αA-Cre line was per-
formed by mating with the ROSA26  reporter line
(Gt(ROSA)26Sortm1Sor) as described [65]. The β-Actin/Cre
transgenic mice (FVB/N-Tg(ACTB-cre)2Mrt/J) line MRL
[66] were purchased from Jackson laboratories (Bar Har-
bor, Maine, USA). Cre mice were crossed with the Rybp
transgenic mice (see next) to obtain F1 Rybp transgenic
mice (FVB).
Mice were housed in a 12-h light, 12-h dark cycle and
maintained in the animal facility at AECOM in accord-
ance with institutional guidelines. Noon of the day the
vaginal plug was observed was considered E0.5 of embry-
ogenesis. For genotyping targeted ES cell colonies/mice,
EGFP  Primers: A, (5'-aagttcatctgcaccaccg-3') and B, (5'-
tgctcaggtagtggttgtcg-3') were used as described. The geno-
types were determined by PCR analysis on DNA extracted
from the tail or yolk sac.
Rybp conditional transgenics
The strategy used to generate a Cre recombinase-mediated
conditional ectopic Rybp allele by targeting the ubiquitous
ROSA26 locus is shown on Figure 6. The ROSA26 locus
(referred to as an R26 knock-in) was targeted with a floxed
neo cassette followed by an RYBP/EGFP fusion. To gener-
ate the RYBP/EGFP fusion, the Rybp open reading frame
(ORF) was amplified with primers A (5'-gcacgtcgac-
cagcccgtccatgaccatgg-3') and B (5'-ctctggatccgaaagattcat-
cattcactgc 3') and cloned into pEGFP-N3 with NheI/SalI.
The Rybp/EGFP fusion was transferred to pBigT [41] with
NheI/Not1, and then the Rybp/EGFP together with the
floxed neomycin cassette was cloned into the pROSA26
vector [41] with AscI/PacI. Rybp transgenic ES cell lines
were generated by electroporating linearized targeting vec-
tor into R1 ES cells [63] as described in 96 clones resistant
to G418 (Gibco, 300 μg/ml) were selected, and screened
by genomic Southern blot hybridization on DNA digested
with EcoRV as previously described [41]. Two targeted
clones were injected into C57BL/6 blastocysts and pro-
duced germ-line chimeras (ROSA26-RYBP/EGFP  mice)
[67]; mice carrying the targeted allele were genotyped by
the PCR as described [41]. Male chimeras were mated with
ICR females, and their agouti offspring were tested for
transmission by tail PCR and blotting. Animals hetero-
zygous for the mutation were bred with corresponding
Cre transgenic lines and analyzed for the phenotype. Non-
transgenic littermates were used as controls for all experi-
ments. Heterozygous transgenic progeny were mated to
maintain the allele. All analyses were performed on a
mixed (129 × ICR) background and mutant mice were
analyzed in comparison to their wild-type littermates.
Histology and immunohistochemistry
All embryos were dissected in PBS, fixed overnight in PBS
buffered 4% paraformaldehyde, and paraffin-embedded
sections (6 μm) were mounted for staining. For immuno-
histochemistry, deparaffinized and rehydrated tissue
slides were first treated for 30 min with 3% H2O2 to inac-
tivate endogenous peroxidases. After rinsing washing in
PBS for 5–10 min, slides were blocked with 10% (w/v)
BSA in PBS and then incubated overnight at 4°C with
antibodies against Rybp (anti-DEDAF; dilution 1:1000;
Chemicon, AB3637; rabbit), Pax2 (dilution 1:200, Babco,
PRB276P, rabbit), Pax6 (dilution 1:500, mouse IgG1,
DSHB), Nestin (dilution: 1:100, mouse IgG1, DSHB Rat-
401), NeuN (dilution: 1:1000, Chemicon MAB377), or
TUJ1 (dilution: 1:2000, Sigma T8660). After removing
excess antibody, samples were incubated with a 1:400
dilution of biotin-conjugated secondary anti-rabbit
(Dako, EO466) or anti-mouse antibodies (Dako, EO433)
for 45 minutes at room temperature, washed in PBS, and
incubated with avidin-biotinylated enzyme complex for
45 minutes. The reaction was developed with the DAB kit
(Vector labs). For better visualization, slides were oftenBMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
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slightly counterstained with hematoxylin. Samples were
viewed and photographed under epifluorescent illumina-
tion with Leica MZFLIII microscope.
Electron microscopy
Dissected P1 and P21 day old eyes were placed in Ito's fix-
ative [68] for 24 h after the cornea had been pierced with
a fine needle. The eyes were washed overnight in
cacodylate buffer, postfixed with OsO4, dehydrated, and
embedded in Epon (Roth, Karlsruhe, Germany). Semithin
sections were stained with toluidine blue. Ultrathin sec-
tions were stained with uranyl acetate and lead citrate and
viewed with a Zeiss (Oberkochen, Germany) EM 902 elec-
tron microscope.
Western blots
Western blotting analysis was conducted upon protein
extracts from embryonic stem cells as described earlier
[32]. Primary antibodies were used against RYBP (anti-
DEDAF; 1:1,000, Chemicon AB3637), GFP (1:1,000,
Molecular Probes A11122) and Flag HRP (1:5000, M2,
Sigma).
Quantitative RT-PCR
Total RNA isolated from the lens and retina of the
ROSA26-Rybp/EGFP; αA-crystallin/Cre P1 and P21 day old
mice was extracted and reverse transcript was obtained as
described elsewhere [16]. Real time PCR was performed as
previously described using primers to amplify Pax6, Prox1,
MafA, MafB and c-Maf transcripts [69,70]). The additional
primers are: Rybp primers A, (5'-agaccagcgaaacaaaccac-3')
and B, (5'-aggaggagcgagtcttttcc-3'); Crystallin βA4 (Cryba4)
primers A, (5'-gggtttgttcccagttcct-3') and B, (5'-acctgagtggt-
gatcgctct-3');  Filensin (Bfsp1) Primers: A, (5'-cattgagatt-
gaaggcagca-3') B, (5'-acactggatccaaggctgag-3'); AP2α
primer A, (5'-gtgtcagagatgctgcggta-3') and B (5'-tgaggat-
ggtgtccacgta-3'); Integrin α-6 primers A, (5'-attctcctgagggct-
tccat-3') and B, (5'-ttgagggaaacaccgtcact-3'); Sox2 primer
A, (5'-acttttgtccgagaccgaga-3') and B, (5'-ctccggcaagcgtg-
tactta-3'); and B2M primers A, (5'-catacgcctgcagagttaagc-
3') and B, (5'-gatgcttgatcacatgtctcg-3'). Amplification of
the cDNA was performed using 7900 HP Applied Biosys-
tems Real Time PCR machine. Relative fold changes were
calculated using CCNI as an internal control as described
[70].
Abbreviations
C; cornea, Ca; capillary, CA; cataract, Co; cortex, Col; colo-
boma, Cre; Cre recombinase, E; embryonic day, Ep; cor-
neal epithelium, GCL; ganglion cell layer, EGFP;
enhanced green fluorescent protein, H; hyaloid cavity,
HE; hematoxylin and eosin, INL; inner nuclear layer, L;
lens, LE; lens epithelium, M; marginal, ME; mesenchyme,
NE; neuroepithelium, NR; neuroretina, P; postnatal day,
PLF; primary lens fiber cells, PcG; polycomb group pro-
tein; OC; optic cup, ON; optic nerve, ONL; outer nuclear
layer, ORF; open reading frame, PCR; polymerase chain
reaction, PM; periocular mesenchyme, qRT-PCR; quanti-
tative reverse transcriptase – polymerase chain reaction; S;
stroma, SE; surface ectoderm, T; transitional zone, V; ven-
tral, TG; transgenic, WT; wild type
Authors' contributions
M.K.P, N.S.A and A.C. conceived the project, designed the
experiments, and wrote the manuscript. M.K.P. performed
most of the experimental manipulations. W.W. carried
out the RT-PCR analyses. L.V.W. contributed to the phe-
notypic analyses. E.T. performed the E.M. experiments
and contributed to the phenotypic analyses. All authors
read and modified drafts, and approved the final manu-
script.
Acknowledgements
We are grateful to Dr. M.L. Robinson (Miami University, Oxford, OH) for 
the αA-crystallin/cre transgenic mice. We thank the Histopathology Shared 
Resource of the Albert Einstein Cancer Center for histology, Radma Mah-
mood and Kveta Cveklova for superb technical assistance. We thank Dr. 
J.D. Locker for his kind help during revisions of this manuscript. This work 
was supported by NIH grants EY12200 and 14237 (AC) and CA92558 
(NSA). A.C. is a recipient of the Irma T. Hirschl Career Scientist Award.
References
1. Marquardt T, Ashery-Padan R, Andrejewski N, Scardigli R, Guillemot
F, Gruss P: Pax6 is required for the multipotent state of reti-
nal progenitor cells.  Cell 2001, 105:43-55.
2. Donner AL, Maas RL: Conservation and non-conservation of
genetic pathways in eye specification.  Int J Dev Biol 2004,
48:743-53.
3. Graw J: The genetic and molecular basis of congenital eye
defects.  Nat Rev Genet 2003, 4:876-88.
4. Mui SH, Kim JW, Lemke G, Bertuzzi S: Vax genes ventralize the
embryonic eye.  Genes Dev 2005, 19:1249-59.
5. Gregory-Evans CY, Williams MJ, Halford S, Gregory-Evans K: Ocular
coloboma: a reassessment in the age of molecular neuro-
science.  J Med Genet 2004, 41:881-91.
6. Barbieri AM, Lupo G, Bulfone A, Andreazzoli M, Mariani M, Fouger-
ousse F, Consalez GG, Borsani G, Beckmann JS, Barsacchi G, et al.: A
homeobox gene, vax2, controls the patterning of the eye
dorsoventral axis.  Proc Natl Acad Sci USA 1999, 96:10729-34.
7. Piatigorsky J: Lens differentiation in vertebrates. A review of
cellular and molecular features.  Differentiation 1981, 19:134-53.
8. Hejtmancik JF, Kantorow M: Molecular genetics of age-related
cataract.  Exp Eye Res 2004, 79:3-9.
9. Lupo G, Harris WA, Lewis KE: Mechanisms of ventral patterning
in the vertebrate nervous system.  Nat Rev Neurosci 2006,
7:103-14.
10. Bailey TJ, El-Hodiri H, Zhang L, Shah R, Mathers PH, Jamrich M: Reg-
ulation of vertebrate eye development by Rx genes.  Int J Dev
Biol 2004, 48:761-70.
11. Lang RA: Pathways regulating lens induction in the mouse.  Int
J Dev Biol 2004, 48:783-91.
12. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Ran-
dazzo F, Metzger D, Chambon P, Crabtree G, et al.: A Brg1 null
mutation in the mouse reveals functional differences among
mammalian SWI/SNF complexes.  Mol Cell 2000, 6:1287-95.
13. Stopka T, Skoultchi AI: The ISWI ATPase Snf2h is required for
early mouse development.  Proc Natl Acad Sci USA 2003,
100:14097-102.
14. Kamachi Y, Uchikawa M, Collignon J, Lovell-Badge R, Kondoh H:
Involvement of Sox1, 2 and 3 in the early and subsequent
molecular events of lens induction.  Development 1998,
125:2521-32.BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
Page 13 of 14
(page number not for citation purposes)
15. Gregg RG, Willer GB, Fadool JM, Dowling JE, Link BA: Positional
cloning of the young mutation identifies an essential role for
the Brahma chromatin remodeling complex in mediating
retinal cell differentiation.  Proc Natl Acad Sci USA 2003,
100:6535-40.
16. Yang Y, Stopka T, Golestaneh N, Wang Y, Wu K, Li A, Chauhan BK,
Gao CY, Cveklova K, Duncan MK, et al.: Regulation of alphaA-
crystallin via Pax6, c-Maf, CREB and a broad domain of lens-
specific chromatin.  Embo J 2006, 25:2107-18.
17. Furuta Y, Hogan BL: BMP4 is essential for lens induction in the
mouse embryo.  Genes Dev 1998, 12:3764-75.
18. Taranova OV, Magness ST, Fagan BM, Wu Y, Surzenko N, Hutton SR,
Pevny LH: SOX2 is a dose-dependent regulator of retinal neu-
ral progenitor competence.  Genes Dev 2006, 20:1187-202.
19. West-Mays JA, Zhang J, Nottoli T, Hagopian-Donaldson S, Libby D,
Strissel KJ, Williams T: AP-2alpha transcription factor is
required for early morphogenesis of the lens vesicle.  Dev Biol
1999, 206:46-62.
20. Dwivedi DJ, Pontoriero GF, Ashery-Padan R, Sullivan S, Williams T,
West-Mays JA: Targeted deletion of AP-2alpha leads to disrup-
tion in corneal epithelial cell integrity and defects in the cor-
neal stroma.  Invest Ophthalmol Vis Sci 2005, 46:3623-30.
21. Morgenbesser SD, Williams BO, Jacks T, DePinho RA: p53-depend-
ent apoptosis produced by Rb-deficiency in the developing
mouse lens.  Nature 1994, 371:72-4.
22. McCaffrey J, Yamasaki L, Dyson NJ, Harlow E, Griep AE: Disruption
of retinoblastoma protein family function by human papillo-
mavirus type 16 E7 oncoprotein inhibits lens development in
part through E2F-1.  Mol Cell Biol 1999, 19:6458-68.
23. Garcia E, Marcos-Gutierrez C, del Mar Lorente M, Moreno JC, Vidal
M: RYBP, a new repressor protein that interacts with com-
ponents of the mammalian Polycomb complex, and with the
transcription factor YY1.  Embo J 1999, 18:3404-18.
24. Buszczak M, Spradling AC: Searching chromatin for stem cell
identity.  Cell 2006, 125:233-6.
25. Pirrotta V: Ernst Schering Res Found Workshop 2006:97-113.
26. Bejarano F, Gonzalez I, Vidal M, Busturia A: The Drosophila RYBP
gene functions as a Polycomb-dependent transcriptional
repressor.  Mech Dev 2005, 122:1118-29.
27. Kalenik JL, Chen D, Bradley ME, Chen SJ, Lee TC: Yeast two-hybrid
cloning of a novel zinc finger protein that interacts with the
multifunctional transcription factor YY1.  Nucleic Acids Res
1997, 25:843-9.
28. Schlisio S, Halperin T, Vidal M, Nevins JR: Interaction of YY1 with
E2Fs, mediated by RYBP, provides a mechanism for specifi-
city of E2F function.  Embo J 2002, 21:5775-86.
29. Ogawa H, Ishiguro K, Gaubatz S, Livingston DM, Nakatani Y: A com-
plex with chromatin modifiers that occupies E2F- and Myc-
responsive genes in G0 cells.  Science 2002, 296:1132-6.
30. Zheng L, Schickling O, Peter ME, Lenardo MJ: The death effector
domain-associated factor plays distinct regulatory roles in
the nucleus and cytoplasm.  J Biol Chem 2001, 276:31945-52.
31. Arrigoni R, Alam SL, Wamstad JA, Bardwell VJ, Sundquist WI, Sch-
reiber-Agus N: The Polycomb-associated protein Rybp is a
ubiquitin binding protein.  FEBS Lett 2006, 580:6233-41.
32. Pirity MK, Locker J, Schreiber-Agus N: Rybp/DEDAF is required
for early postimplantation and for central nervous system
development.  Mol Cell Biol 2005, 25:7193-202.
33. Torres M, Gomez-Pardo E, Gruss P: Pax2 contributes to inner
ear patterning and optic nerve trajectory.  Development 1996,
122:3381-91.
34. Hogan BL, Horsburgh G, Cohen J, Hetherington CM, Fisher G, Lyon
MF: Small eyes (Sey): a homozygous lethal mutation on chro-
mosome 2 which affects the differentiation of both lens and
nasal placodes in the mouse.  J Embryol Exp Morphol 1986,
97:95-110.
35. Walther C, Gruss P: Pax-6, a murine paired box gene, is
expressed in the developing CNS.  Development 1991,
113:1435-49.
36. Grindley JC, Davidson DR, Hill RE: The role of Pax-6 in eye and
nasal development.  Development 1995, 121:1433-42.
37. Sanyanusin P, McNoe LA, Sullivan MJ, Weaver RG, Eccles MR: Muta-
tion of PAX2 in two siblings with renal-coloboma syndrome.
Hum Mol Genet 1995, 4:2183-4.
38. Favor J, Sandulache R, Neuhauser-Klaus A, Pretsch W, Chatterjee B,
Senft E, Wurst W, Blanquet V, Grimes P, Sporle R, et al.: The mouse
Pax2(1Neu) mutation is identical to a human PAX2 muta-
tion in a family with renal-coloboma syndrome and results in
developmental defects of the brain, ear, eye, and kidney.  Proc
Natl Acad Sci USA 1996, 93:13870-5.
39. Schwarz M, Cecconi F, Bernier G, Andrejewski N, Kammandel B,
Wagner M, Gruss P: Spatial specification of mammalian eye
territories by reciprocal transcriptional repression of Pax2
and Pax6.  Development 2000, 127:4325-34.
40. Livesey FJ, Young TL, Cepko CL: An analysis of the gene expres-
sion program of mammalian neural progenitor cells.  Proc Natl
Acad Sci USA 2004, 101:1374-9.
41. Srinivas S, Watanabe T, Lin CS, William CM, Tanabe Y, Jessell TM,
Costantini F: Cre reporter strains produced by targeted inser-
tion of EYFP and ECFP into the ROSA26 locus.  BMC Dev Biol
2001, 1:4.
42. Martinez-Morales JR, Signore M, Acampora D, Simeone A, Bovolenta
P: Otx genes are required for tissue specification in the devel-
oping eye.  Development 2001, 128:2019-30.
43. Baulmann DC, Ohlmann A, Flugel-Koch C, Goswami S, Cvekl A,
Tamm ER: Pax6 heterozygous eyes show defects in chamber
angle differentiation that are associated with a wide spec-
trum of other anterior eye segment abnormalities.  Mech Dev
2002, 118:3-17.
44. Medina-Martinez O, Brownell I, Amaya-Manzanares F, Hu Q,
Behringer RR, Jamrich M: Severe defects in proliferation and dif-
ferentiation of lens cells in Foxe3 null mice.  Mol Cell Biol 2005,
25:8854-63.
45. Chen Q, Liang D, Yang T, Leone G, Overbeek PA: Distinct capaci-
ties of individual E2Fs to induce cell cycle re-entry in postmi-
totic lens fiber cells of transgenic mice.  Dev Neurosci 2004,
26:435-45.
46. Lovicu FJ, McAvoy JW: Growth factor regulation of lens devel-
opment.  Dev Biol 2005, 280:1-14.
47. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai
Y, Silver M, Isner JM: VEGF contributes to postnatal neovascu-
larization by mobilizing bone marrow-derived endothelial
progenitor cells.  Embo J 1999, 18:3964-72.
48. Kato T, Kure T, Chang JH, Gabison EE, Itoh T, Itohara S, Azar DT:
Diminished corneal angiogenesis in gelatinase A-deficient
mice.  FEBS Lett 2001, 508:187-90.
49. Berglin L, Sarman S, van der Ploeg I, Steen B, Ming Y, Itohara S, Sere-
gard S, Kvanta A: Reduced choroidal neovascular membrane
formation in matrix metalloproteinase-2-deficient mice.
Invest Ophthalmol Vis Sci 2003, 44:403-8.
50. Samolov B, Steen B, Seregard S, van der Ploeg I, Montan P, Kvanta A:
Delayed inflammation-associated corneal neovasculariza-
tion in MMP-2-deficient mice.  Exp Eye Res 2005, 80:159-66.
51. Pirrotta V, van Lohuizen M: Differentiation and gene regulation
Genomic programs and differentiation.  Curr Opin Genet Dev
2006.
52. Muyrers-Chen I, Hernandez-Munoz I, Lund AH, Valk-Lingbeek ME,
van der Stoop P, Boutsma E, Tolhuis B, Bruggeman SW, Taghavi P,
Verhoeven E, et al.: Emerging roles of Polycomb silencing in X-
inactivation and stem cell maintenance.  Cold Spring Harb Symp
Quant Biol 2004, 69:319-26.
53. Raaphorst FM: Of mice, flies, and man: the emerging role of
polycomb-group genes in human malignant lymphomas.  Int
J Hematol 2005, 81:281-7.
54. Cernilogar FM, Orlando V: Epigenome programming by Poly-
comb and Trithorax proteins.  Biochem Cell Biol 2005, 83:322-31.
55. Gil J, Bernard D, Peters G: Role of polycomb group proteins in
stem cell self-renewal and cancer.  DNA Cell Biol 2005,
24:117-25.
56. Ringrose L, Paro R: Epigenetic regulation of cellular memory
by the Polycomb and Trithorax group proteins.  Annu Rev
Genet 2004, 38:413-43.
57. Levine SS, King IF, Kingston RE: Division of labor in polycomb
group repression.  Trends Biochem Sci 2004, 29:478-85.
58. Takihara Y, Tomotsune D, Shirai M, Katoh-Fukui Y, Nishii K, Motaleb
MA, Nomura M, Tsuchiya R, Fujita Y, Shibata Y, et al.: Targeted dis-
ruption of the mouse homologue of the Drosophila poly-
homeotic gene leads to altered anteroposterior patterning
and neural crest defects.  Development 1997, 124:3673-82.
59. Lorente M, Perez C, Sanchez C, Donohoe M, Shi Y, Vidal M: Home-
otic transformations of the axial skeleton of YY1 mutantPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Developmental Biology 2007, 7:39 http://www.biomedcentral.com/1471-213X/7/39
Page 14 of 14
(page number not for citation purposes)
mice and genetic interaction with the Polycomb group gene
Ring1/Ring1A.  Mech Dev 2006, 123:312-20.
60. Nottoli T, Hagopian-Donaldson S, Zhang J, Perkins A, Williams T:
AP-2-null cells disrupt morphogenesis of the eye, face, and
limbs in chimeric mice.  Proc Natl Acad Sci USA 1998, 95:13714-9.
61. Kamachi Y, Uchikawa M, Tanouchi A, Sekido R, Kondoh H: Pax6 and
SOX2 form a co-DNA-binding partner complex that regu-
lates initiation of lens development.  Genes Dev 2001,
15:1272-86.
62. Wistow GJ, Piatigorsky J: Lens crystallins: the evolution and
expression of proteins for a highly specialized tissue.  Annu Rev
Biochem 1988, 57:479-504.
63. Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder JC: Deri-
vation of completely cell culture-derived mice from early-
passage embryonic stem cells.  Pro c Natl Acad Sci USA 1993,
90:8424-8.
64. Zhao H, Yang Y, Rizo CM, Overbeek PA, Robinson ML: Insertion of
a Pax6 consensus binding site into the alphaA-crystallin pro-
moter acts as a lens epithelial cell enhancer in transgenic
mice.  Invest Ophthalmol Vis Sci 2004, 45:1930-9.
65. Soriano P: Generalized lacZ expression with the ROSA26 Cre
reporter strain.  Nat Genet 1999, 21:70-1.
66. Lewandoski M, Meyers EN, Martin  GR: Analysis of Fgf8 gene
function in vertebrate development.  Cold Spring Harb Symp
Quant Biol 1997, 62:159-168.
67. Chowdhury K, Bonaldo P, Torres M, Stoykova A, Gruss P: Evidence
for the stochastic integration of gene trap vectors into the
mouse germline.  Nucleic Acids Res 1997, 25:1531-6.
68. Ito SKM: Formaldehyde-glutaraldehyde fixatives containing
trinitro compounds.  J Cell Biol 1968, 39:168A-169A.
69. Yang Y, Cvekl A: Tissue-specific regulation of the mouse
alphaA-crystallin gene in lens via recruitment of Pax6 and c-
Maf to its promoter.  J Mol Biol 2005, 351:453-69.
70. Livak KJ, Schmittgen TD: Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta
C(T)) Method.  Methods 2001, 25:402-8.